Globally, as a leading agent of acute respiratory tract infections in children < 5 years of age and the elderly, the human metapneumovirus (HMPV) has gained considerable attention. As inferred from studies comparing vaccinated and experimentally infected
Selecciona los documentos para visualizarlos
Nombre del archivo | Ver recurso |
---|